PTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Prescient Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.065 AUD -4.41% Market Closed

Market Cap: AU$68.3m

	Prescient Therapeutics Ltd ASX:PTX	AU
	Carnegie Clean Energy Ltd ASX:CCE	AU
C	Canada Nickel Company Inc OTC:CNIKF	CA
	Pitney Bowes Inc NYSE:PBI	US
H	Hyatt Hotels Corp XMUN:1HTA	US
	DevEx Resources Ltd ASX:DEV	AU
	Orion SA NYSE:OEC	LU
	Praemium Ltd ASX:PPS	AU
I	i-Components Co Ltd KOSDAQ:059100	KR
	Crescent Biopharma Inc (Pre-Reincorporation) NASDAQ:CBIO	US

Profitability Summary

Prescient Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-25.420%

Negative 3Y Average Operating Margin

-6.420%

Declining Operating Margin

-1.538% > -25.420%

Negative Net Margin

-25.387%

Negative 3Y Average Net Margin

-6.468%

Declining Net Margin

-1.526% > -25.387%

Negative Free Cash Flow Margin

-22.915%

Negative 3Y Average Free Cash Flow Margin

-6.044%

Declining Free Cash Flow Margin

-1.349% > -22.915%

Negative ROE

-54%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-148%

ROIC is Increasing

-156% > -118%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.